非典型的TDP-43蛋白质病变临床呈现与渐进的非流动性失语症:一个病例报告
Yuki Suzuki1, Tadashi Adachi2, Kentaro Yoshida1
1Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Japan.
Neuropathology : official journal of the Japanese Society of Neuropathology
|September 17, 2023
概括
这项研究详细介绍了一种非典型的43kDa (TDP-43) 蛋白质异常的交换性反应DNA结合蛋白的案例,这种蛋白质异常呈现为渐进性非流动性失语症 (PNFA). 尸检发现了独特的病理发现,表明前叶退化与TDP-43病理学的潜在新现型.
科学领域:
- 神经病理学神经病理学
- 神经退行性疾病 神经退行性疾病
- 分子生物学分子生物学
背景情况:
- 渐进性非流动性失语症 (PNFA) 是一种临床综合征,通常与前叶退化 (FTLD) 相关,其特征是tau或交换性反应DNA结合蛋白43kDa (TDP-43) 病理.
- TDP-43蛋白病变代表了FTLD的一个重要子集,具有明显的临床病理亚型.
研究的目的:
- 报告FTLD-TDP异常呈现的患者的详细尸检结果.
- 描述神经病理特征,包括蛋白质聚合和分布.
- 确定观察到的病理是否代表FTLD-TDP的已知或新型亚型.
主要方法:
- 大脑的宏观检查.
- 组织病理学分析,包括对化TDP-43的免疫染.
- 脑组织部分的免疫块分析.
主要成果:
- 尸体解剖显示,特定的额头环形缩和门变色.
- 在皮层区域观察到严重的海绵状变化和神经元损失.
- 免疫测试显示TDP-43在神经元细胞质和神经元中包含在特定皮层和皮层下区域内的神经元.
- 免疫洗证实了高酸化的TDP-43和C端碎片.
结论:
- 这位患者呈现PNFA和失足症的临床特征.
- 独特的TDP-43病理分布和免疫斑块特征使这种病例与主要的FTLD-TDP亚型区别开来.
- 这些发现表明FTLD-TDP的潜在新型表型.
相关概念视频
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Parkinson's Disease: Overview
592
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
Dementia
139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
139


